← Back to patent-cliff list
Granisetron
Tier C — Watch / tradeGranisetron
Kyowa Hakko Kirin Co Ltd
Originator
1997
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT3
Brand：Sancuso, Sustol
Indications (approved)：Chemotherapy-induced nausea and vomiting, Nausea, 呕吐, 手术后恶心呕吐
Regional status
US
Approved
2008-09-12
EU
Approved
2012-04-20
China
Approved
1997-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Granisetron?
Approved indications include: Chemotherapy-induced nausea and vomiting, Nausea, 呕吐, 手术后恶心呕吐.
When does the Granisetron patent expire?
No public expiry year is available for Granisetron yet; this page updates once verified.
How do I get a quote for Granisetron intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27